{
    "Orphapacket": {
        "ORPHApacketId": "309147",
        "creationDate": "2023-06-19 09:22:44",
        "version": "1.3.25 / 4.1.7 [2023-04-17] (orientdb version)",
        "copyright": "Orphanet (c) 2023",
        "ORPHAcode": "309147",
        "Label": "Hyper-beta-alaninemia",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_309147",
        "DisorderType": {
            "value": "Disease",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377788"
        },
        "Synonyms": [
            {
                "Synonym": "Hyperalaninemia"
            }
        ],
        "ExternalReferences": [
            {
                "Source": "OMIM",
                "Reference": "237400",
                "DisorderMappingRelation": "E (Exact mapping: the two concepts are equivalent)"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "A rare genetic disorder of pyrimidine metabolism characterized by increased serum beta-alanine levels and severe phenotype including hypotonia malaise seizures respiratory distress lethargy and encephalopathy. Urinary excretion of beta-alanine beta-amino-isobutyric acid taurine and gamma-amino-butyric acid is also elevated. There have been no further descriptions in the literature since 1994."
        },
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "79193",
                        "Label": "Disorder of pyrimidine metabolism"
                    }
                ]
            },
            {
                "Parent": [
                    {
                        "ORPHAcode": "166481",
                        "Label": "Metabolic diseases with epilepsy"
                    }
                ]
            },
            {
                "Parent": [
                    {
                        "ORPHAcode": "225689",
                        "Label": "Amino acid or protein metabolism disease with epilepsy"
                    }
                ]
            }
        ],
        "Prevalences": [
            {
                "Prevalence": {
                    "Source": "17926374[PMID]_7936305[PMID]_ORPHANET",
                    "PrevalenceType": "Cases/families",
                    "PrevalenceQualification": "Case",
                    "PrevalenceClass": "no data",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Worldwide"
                }
            },
            {
                "Prevalence": {
                    "Source": "ORPHANET_17926374[PMID]_7936305[PMID]",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Class only",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Worldwide"
                }
            }
        ],
        "AverageAgeOfOnsets": {
            "AverageAgeOfOnset": [
                {
                    "value": "Neonatal"
                }
            ]
        }
    }
}